Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Patent save search
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
MNPR | $0.63 -3.08% -3.17% 39K
|
Health Technology
|
| O: -3.95%
H: 1.37%
C: 0.0%
mnpr-101 patent
Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
BIOR | $0.6199 -2.99% -3.08% 180K
|
Health Care and Social Assistan...
|
| O: -2.0%
H: 2.61%
C: 2.21%
patent technology therapeutics
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
Published: 2024-04-08 (Crawled : 09:00) - biospace.com/
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: -1.06%
H: 3.5%
C: 0.51%
patent cancer treatment for application
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
OVID | $3.165 -1.09% -1.11% 110K
|
Health Technology
|
| O: 1.67%
H: 1.64%
C: 0.0%
MRNS | $1.44 0.0% 1.5M
|
Health Technology
|
| O: 0.8%
H: 2.37%
C: -0.11%
patent review update pharmaceuticals grant therapeutics
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
VIRI | $0.436 1.16% 1.15% 200K
|
Health Technology
|
| O: 4.41%
H: 8.05%
C: -12.31%
patent antiviral international publication treatment therapeutics
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
CMMB | $0.67 0.02% 3.4K
|
Manufacturing
|
| O: -2.74%
H: 6.8%
C: -2.94%
cm-101 patent antibody
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
SILO | $1.9 6.74% 6.32% 380K
|
Finance and Insurance
|
| O: -6.52%
H: 9.88%
C: 4.07%
ketamine pharma patent fibromyalgia implant
BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
Published: 2024-03-15 (Crawled : 11:00) - globenewswire.com
BTAI | News | $2.7 -9.09% -10.0% 880K
|
Health Technology
|
| O: -1.74%
H: 2.13%
C: -4.96%
patent grant therapeutics
Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
Published: 2024-03-04 (Crawled : 16:00) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: 10.0%
H: 18.18%
C: 9.09%
covid-19 quadramune patent natural granted international cell solutions
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -2.31%
H: 4.72%
C: -3.15%
patent therapeutics
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
Published: 2024-02-20 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.452 -1.72% -1.75% 91K
|
Professional, Scientific, and T...
|
| O: 1.87%
H: 0.0%
C: -1.84%
patent agonist publication application therapeutics
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
Published: 2024-02-15 (Crawled : 12:00) - globenewswire.com
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 0.52%
H: 7.73%
C: 0.52%
patent
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
ENLV | News | $1.52 15.15% 13.16% 130K
|
Health Technology
|
| O: 1.55%
H: 4.96%
C: 1.53%
patent
Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
TENX | $3.51 0.29% 0.28% 7.9K
|
Health Technology
|
| O: 132.91%
H: 5.66%
C: -43.62%
patent application grants therapeutics
Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Published: 2024-02-06 (Crawled : 13:30) - globenewswire.com
TENX | $3.51 0.29% 0.28% 7.9K
|
Health Technology
|
| O: 132.91%
H: 5.66%
C: -43.62%
patent levosimendan hypertension heart grants therapeutics
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
Published: 2024-02-05 (Crawled : 23:00) - biospace.com/
XCUR 4 | $0.511 -5.42% -5.73% 19K
|
Commercial Services
|
| O: 1.1%
H: 1.82%
C: 1.76%
hepatitis patent license treatment therapeutics agreement
BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine
Published: 2024-02-05 (Crawled : 12:00) - globenewswire.com
BTAI | News | $2.7 -9.09% -10.0% 880K
|
Health Technology
|
| O: 9.48%
H: 15.37%
C: 10.75%
patent disease alzheimer’s application therapeutics
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
Published: 2024-01-29 (Crawled : 15:30) - biospace.com/
CYTH | $1.21 7.94% 21K
|
Professional, Scientific, and T...
|
| O: 6.43%
H: 1.58%
C: -2.75%
patent disease alzheimer’s treatment application therapeutics
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
Published: 2024-01-29 (Crawled : 12:00) - globenewswire.com
GDTC | $2.15 -2.04% 990
|
|
| O: 2.17%
H: 0.0%
C: -3.97%
patent granted cell technology
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
Published: 2024-01-24 (Crawled : 14:00) - globenewswire.com
CYTO | $1.495 -5.38% -5.69% 3M
|
Manufacturing
|
| O: 21.43%
H: 1.52%
C: -10.59%
patent cancer treatment application therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.